Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 55 publications
Phase 2/3 Trial of Molnupiravir for Treatment of Covid-19 in Nonhospitalized Adults.
Journal: NEJM evidence
Published: February 01, 2022
Randomized Trial of Molnupiravir or Placebo in Patients Hospitalized with Covid-19.
Journal: NEJM evidence
Published: February 01, 2022
Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients.
Journal: The New England journal of medicine
Published: December 16, 2021
Clinical and microbiological outcomes, by causative pathogen, in the ASPECT-NP randomized, controlled, Phase 3 trial comparing ceftolozane/tazobactam and meropenem for treatment of hospital-acquired/ventilator-associated bacterial pneumonia.
Journal: The Journal of antimicrobial chemotherapy
Published: August 05, 2021
Letter to the Editor in Response to Zhou et al.
Journal: The Journal of infectious diseases
Published: June 07, 2021
Reply to Chao and Lai.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: May 16, 2021
Ceftolozane/tazobactam versus meropenem in patients with ventilated hospital-acquired bacterial pneumonia: subset analysis of the ASPECT-NP randomized, controlled phase 3 trial.
Journal: Critical care (London, England)
Published: February 26, 2021
Evaluation of Pharmacokinetic Drug Interactions of the Direct-Acting Antiviral Agents Elbasvir and Grazoprevir with Pitavastatin, Rosuvastatin, Pravastatin, and Atorvastatin in Healthy Adults.
Journal: Clinical drug investigation
Published: February 02, 2021
Safety and Efficacy of Oral and/or Intravenous Tedizolid Phosphate From a Randomized Phase 3 Trial in Adolescents With Acute Bacterial Skin and Skin Structure Infections.
Journal: The Pediatric infectious disease journal
Published: January 04, 2021
A Phase 3, Randomized, Double-Blind Study Comparing Tedizolid Phosphate and Linezolid for Treatment of Ventilated Gram-Positive Hospital-Acquired or Ventilator-Associated Bacterial Pneumonia.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: September 17, 2020
Reply to Sfeir.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: July 08, 2020
A Randomized, Double-blind, Multicenter Trial Comparing Efficacy and Safety of Imipenem/Cilastatin/Relebactam Versus Piperacillin/Tazobactam in Adults With Hospital-acquired or Ventilator-associated Bacterial Pneumonia (RESTORE-IMI 2 Study).
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: December 23, 2019
Last Updated: 09/26/2026